Image
Brenda Sanchez
Former Developmental Core Manager (2002-2025)
CFAR offered a general Pilot Award program from 1994 to 2017 and funded 82 early stage investigators.
In 2022, CFAR initiated a new program: Pilot Award for Investigators New to HIV.
82 Awards
-
Property Rights and HIVIAIDS Prevention: Examining the Impact of a Community Land and Property WatchDog Model In Nyanza and Western Provinces, Kenya
Property Rights and HIVIAIDS Prevention: Examining the Impact of a Community Land and Property WatchDog Model In Nyanza and Western Provinces, Kenya
Abstract
Poverty and gender inequality are two core structural factors that shape women's vulnerability to HIV/AIDS. Recent research demonstrates that access to and control over assets such as property can empower women, provide them with a secure means of livelihood, prevent food insecurity, and improve household bargaining power, all of which mitigate the negative effects of HIV/AIDS. However, little work has intervened at the intersection of property rights and HIV/AIDS prevention.
-
Barriers to Timely HIV Testing and Treatment
Barriers to Timely HIV Testing and Treatment
Abstract
-
Long-Term Evaluation of Patients Experiencing Virologic Failure of a Protease Inhibitor Containing Regimen Who Choose to Temporarily Discontinue Therapy
Long-Term Evaluation of Patients Experiencing Virologic Failure of a Protease Inhibitor Containing Regimen Who Choose to Temporarily Discontinue Therapy
Abstract
-
Property Rights and HIVIAIDS Prevention: Examining the Impact of a Community Land and Property WatchDog Model In Nyanza and Western Provinces, Kenya
Property Rights and HIVIAIDS Prevention: Examining the Impact of a Community Land and Property WatchDog Model In Nyanza and Western Provinces, Kenya
Abstract
Poverty and gender inequality are two core structural factors that shape women's vulnerability to HIV/AIDS. Recent research demonstrates that access to and control over assets such as property can empower women, provide them with a secure means of livelihood, prevent food insecurity, and improve household bargaining power, all of which mitigate the negative effects of HIV/AIDS. However, little work has intervened at the intersection of property rights and HIV/AIDS prevention.
-
Barriers to Timely HIV Testing and Treatment
Barriers to Timely HIV Testing and Treatment
Abstract
-
Long-Term Evaluation of Patients Experiencing Virologic Failure of a Protease Inhibitor Containing Regimen Who Choose to Temporarily Discontinue Therapy
Long-Term Evaluation of Patients Experiencing Virologic Failure of a Protease Inhibitor Containing Regimen Who Choose to Temporarily Discontinue Therapy
Abstract
-
Implementing a Sampling-based Approach to Measuring Patient Outcomes Among HIV-infected Patients Lost to Follow-up in East Africa: the I-SAMPOLE Study
Implementing a Sampling-based Approach to Measuring Patient Outcomes Among HIV-infected Patients Lost to Follow-up in East Africa: the I-SAMPOLE Study
Abstract
The science of implementation begins with the ability to measure important occurrences in routine, day-to-day clinical care. Although the provision of care and treatment for HIV-infected patients in Africa over the last five years has scaled up rapidly, loss to follow-up (i.e., unknown outcomes) commonly exceeds 40% at 1 year. By precluding knowledge of key events, such as mortality and retention in care, losses systematically impair our ability to measure occurrences in clinical care for the conduct implementation science.
-
REACH Cohort Adherence-Pharmacokinetic Substudy
REACH Cohort Adherence-Pharmacokinetic Substudy
Abstract
Publications:
-
A Placebo-Controlled Pilot Study of Chinese Herbs in HIV Associated Cryptosporidium-Negative Diarrhea
A Placebo-Controlled Pilot Study of Chinese Herbs in HIV Associated Cryptosporidium-Negative Diarrhea
Abstract
-
Implementing a Sampling-based Approach to Measuring Patient Outcomes Among HIV-infected Patients Lost to Follow-up in East Africa: the I-SAMPOLE Study
Implementing a Sampling-based Approach to Measuring Patient Outcomes Among HIV-infected Patients Lost to Follow-up in East Africa: the I-SAMPOLE Study
Abstract
The science of implementation begins with the ability to measure important occurrences in routine, day-to-day clinical care. Although the provision of care and treatment for HIV-infected patients in Africa over the last five years has scaled up rapidly, loss to follow-up (i.e., unknown outcomes) commonly exceeds 40% at 1 year. By precluding knowledge of key events, such as mortality and retention in care, losses systematically impair our ability to measure occurrences in clinical care for the conduct implementation science.